Literature DB >> 263885

In vivo susceptibility of the Legionnaires disease bacterium to ten antimicrobial agents.

V J Lewis, W L Thacker, C C Shepard, J E McDade.   

Abstract

The susceptibility of the Legionnaires disease bacterium to various antimicrobial agents was determined by inoculation of embryonated eggs via the yolk sac. When administered prophylactically, the minimal dose of drug preventing all deaths due to the infection was as follows: rifampin, 0.02 mg; gentamicin, 0.25 mg; streptomycin, 0.39 mg; erythromycin, 0.62 mg; sulfadiazine, 1.56 mg; chloramphenicol, 2.50 mg; and cephalothin, 20.0 mg. Smaller amounts delayed deaths, and larger or equal amounts rendered the embryos free of infection. Oxytetracycline in the largest tested amount, 5.0 mg, protected 80% of the embryos from death, and as little as 0.31 mg delayed death. Chlortetracycline (0.50 mg) and ampicillin (10.0 mg) were ineffective. The six most effective drugs were studied in an experiment in which they were administered at various times after infection in doses that were twice the minimal prophylactic dose preventing all deaths. In this therapeutic experiment, rifampin, and erythromycin allowed 100% survival when given even 72 h after infection; gentamicin, streptomycin, sulfadiazine, and chloramphenicol did so when given 48 h after infection. All six drugs increased mean survival time when administered 72 h after infection.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 263885      PMCID: PMC352256          DOI: 10.1128/AAC.13.3.419

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  5 in total

1.  STAINING RICKETTSIAE IN YOLK-SAC CULTURES.

Authors:  D F GIMENEZ
Journal:  Stain Technol       Date:  1964-05

2.  Cellular fatty acid composition of isolates from Legionnaires disease.

Authors:  C W Moss; R E Weaver; S B Dees; W B Cherry
Journal:  J Clin Microbiol       Date:  1977-08       Impact factor: 5.948

3.  The influence of certain salts, amino acids, sugars, and proteins on the stability of rickettsiae.

Authors:  M R BOVARNICK; J C MILLER; J C SNYDER
Journal:  J Bacteriol       Date:  1950-04       Impact factor: 3.490

4.  Legionnaires' disease: description of an epidemic of pneumonia.

Authors:  D W Fraser; T R Tsai; W Orenstein; W E Parkin; H J Beecham; R G Sharrar; J Harris; G F Mallison; S M Martin; J E McDade; C C Shepard; P S Brachman
Journal:  N Engl J Med       Date:  1977-12-01       Impact factor: 91.245

5.  Legionnaires' disease: isolation of a bacterium and demonstration of its role in other respiratory disease.

Authors:  J E McDade; C C Shepard; D W Fraser; T R Tsai; M A Redus; W R Dowdle
Journal:  N Engl J Med       Date:  1977-12-01       Impact factor: 91.245

  5 in total
  11 in total

Review 1.  Current and emerging Legionella diagnostics for laboratory and outbreak investigations.

Authors:  Jeffrey W Mercante; Jonas M Winchell
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

2.  Intracellular multiplication of Legionnaires' disease bacteria (Legionella pneumophila) in human monocytes is reversibly inhibited by erythromycin and rifampin.

Authors:  M A Horwitz; S C Silverstein
Journal:  J Clin Invest       Date:  1983-01       Impact factor: 14.808

Review 3.  Legionellosis.

Authors:  J A Blackmon; F W Chandler; W B Cherry; A C England; J C Feeley; M D Hicklin; R M McKinney; H W Wilkinson
Journal:  Am J Pathol       Date:  1981-06       Impact factor: 4.307

4.  Hypertension.

Authors:  F O Simpson
Journal:  Br Med J       Date:  1978-09-23

5.  Antimicrobial susceptibility of intracellular Legionella pneumophila.

Authors:  M A Bacheson; H M Friedman; C E Benson
Journal:  Antimicrob Agents Chemother       Date:  1981-11       Impact factor: 5.191

6.  Reclamation of ampicillin sensitivity for the genetic manipulation of Legionella pneumophila.

Authors:  Molly C Sutherland; Joseph P Vogel
Journal:  Appl Environ Microbiol       Date:  2012-05-25       Impact factor: 4.792

7.  Susceptibility of Legionella pneumophila to ofloxacin in vitro and in experimental Legionella pneumonia in guinea pigs.

Authors:  A Saito; K Sawatari; Y Fukuda; M Nagasawa; H Koga; A Tomonaga; H Nakazato; K Fujita; Y Shigeno; Y Suzuyama
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

8.  Bactericidal activity of antibiotics against Legionella micdadei (Pittsburgh pneumonia agent).

Authors:  J N Dowling; R S Weyant; A W Pasculle
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

9.  Disk diffusion antimicrobial susceptibility testing of members of the family Legionellaceae including erythromycin-resistant variants of Legionella micdadei.

Authors:  J N Dowling; D A McDevitt; A W Pasculle
Journal:  J Clin Microbiol       Date:  1984-06       Impact factor: 5.948

10.  Inhibition of Legionella pneumophila multiplication within human macrophages by antimicrobial agents.

Authors:  J L Vildé; E Dournon; P Rajagopalan
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.